Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

News & Analysis

China biotech company and industry news and analysis...

BeiGene PD-(L)1 Inhibitor Approved in US for Esophageal Carcinoma

KeChow Approved to Launch Tunlametinib for Melanoma Patients in China

Week in Review: Under Pressure from US Congress, WuXi AppTec Resigns from BIO

Boehringer Options Schizophrenia Candidate from Japan’s Sosei in $822 Million Deal

Hansoh Adds Global Rights for Zhuhai’s Bispecific in $700 Million Deal

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital